Medivate Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

Medivate Partners’ most common sector for investment islife science (100%). The Firm’s most common investment types include growth capital (67%) and buyout (lbo, mbo, mbi) (34%). In total, Medivate Partners has invested in 2 US states and 2 different countries.

In the last 3 years, Medivate Partners has exited 2 companies. The Firm’s most common exit type is trade sale (100%). Medivate Partners’ largest (disclosed) exit occurred in 2021 when it sold Cognate BioServices for $875M.

Join Mergr to view Medivate Partners’ full profile and discover more small private equity firm investors just like it.

M&A Summary

  • M&A Total Activity5
    • M&A Buy Activity3
    • M&A Sell Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 4

Medivate Partners

15F, Kwangil Plaza, 331,Gangnam-daero, Seocho-gu,
Seoul, 06627
South Korea
+82-2-536-0705
www.medivatepartners.com
info@medivatepartners.com

Medivate Partners is a private equity and venture capital firm focused on investment in the biotech/healthcare industry. The Firm looks will consider companies throughout Asia and North America and has a particular interest in businesses that can capitalize on cross border opportunities. Medivate Partners was established in 2012 and is headquartered in Seoul.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Canada, Asia/Pacific

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 3 - - - - - 3
Sell (0.4/yr) # - - 2 - - - 2
vol $875M $875M
  5

Most Recent M&A

Company Date Value Type
WCCT Global LLC 2021-02-19 - Trade Sale
Cypress, California · www.wcct.com
Cognate BioServices, Inc. 2021-02-17 875M USD Trade Sale
Memphis, Tennessee · www.cognatebioservices.com
Cognate BioServices, Inc. 2018-02-20 - Buyout (LBO, MBO, MBI)
Memphis, Tennessee · www.cognatebioservices.com
SillaJen Biotherapeutics 2016-03-21 - Growth Capital
Busan, South Korea · www.sillajen.com
WCCT Global LLC 2015-06-26 - Growth Capital
Cypress, California · www.wcct.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 1 (100%) - 3 (100%) -
Total 1 - 3 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States - - 2 (67%) -
  Tennessee - - 1 (33%) -
  California - - 1 (33%) -
South Korea 1 (100%) - 1 (33%) -
Total 1 - 3 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Growth Capital 1 (100%) - 2 (67%) -
Buyout (LBO, MBO, MBI) - - 1 (33%) -
Total 1 - 3 -

Exits by Deal Type

Type Total # Value
Trade Sale 2 (100%) 875M (100%)
Total 2 $875M

Deal Values

sell # Total
$100M to $1B 1 $875M
TOTAL $875M
Largest Cognate BioServices, Inc.
$875M (2021-02-17)

M&A Connections

Deals
Exited to
Strategic(s)
100%
2 (100%)

Investor Summary

Investor Type

Private Equity Firm

Size

Small

Established

2002

Specialist/Generalist

Specialist

Leadership

Bon Hyuk Koo

Managing Partner

Roger Kang

Managing Partner

Stanley Daewha Jung

Senior Principal

Hwan Jin Lee

Director

Hwayeon Sohn

Director

FAQ

When was Medivate Partners founded?

Medivate Partners was founded in 2002.

What type of investor is Medivate Partners?

Medivate Partners is a private equity firm.

Where is Medivate Partners headquartered?

Medivate Partners is headquartered in Seoul, South Korea.

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal